Yusuke Ishibashi

811 total citations
51 papers, 582 citations indexed

About

Yusuke Ishibashi is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yusuke Ishibashi has authored 51 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 19 papers in Pulmonary and Respiratory Medicine and 16 papers in Oncology. Recurrent topics in Yusuke Ishibashi's work include Esophageal Cancer Research and Treatment (17 papers), Inflammatory Biomarkers in Disease Prognosis (9 papers) and Gastric Cancer Management and Outcomes (6 papers). Yusuke Ishibashi is often cited by papers focused on Esophageal Cancer Research and Treatment (17 papers), Inflammatory Biomarkers in Disease Prognosis (9 papers) and Gastric Cancer Management and Outcomes (6 papers). Yusuke Ishibashi collaborates with scholars based in Japan and United States. Yusuke Ishibashi's co-authors include Hideki Ueno, Hironori Tsujimoto, Yoji Kishi, Keita Kouzu, Yoshihisa Yaguchi, Nozomi Ito, Shinsuke Nomura, Hidekazu Sugasawa, Chikara Οhyama and Sachiko Hommura and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Alloys and Compounds.

In The Last Decade

Yusuke Ishibashi

46 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yusuke Ishibashi Japan 15 212 210 181 117 66 51 582
Vivek R. Sharma United States 14 193 0.9× 176 0.8× 125 0.7× 125 1.1× 41 0.6× 52 777
Satoshi Kobayashi Japan 17 349 1.6× 385 1.8× 266 1.5× 81 0.7× 34 0.5× 81 756
Maria Sotiropoulou Greece 18 181 0.9× 343 1.6× 184 1.0× 145 1.2× 117 1.8× 113 1.0k
Edwin Boelke Germany 13 284 1.3× 186 0.9× 171 0.9× 94 0.8× 110 1.7× 39 694
Chiaki Okuse Japan 14 120 0.6× 142 0.7× 158 0.9× 111 0.9× 55 0.8× 92 924
Martha M. Kirstein Germany 19 384 1.8× 423 2.0× 270 1.5× 178 1.5× 157 2.4× 65 1.2k
Ahmet Emre Eşkazan Türkiye 15 125 0.6× 65 0.3× 88 0.5× 109 0.9× 15 0.2× 130 813
CK Lee South Korea 16 160 0.8× 238 1.1× 68 0.4× 272 2.3× 88 1.3× 40 939
Theodore Thomas United States 11 137 0.6× 98 0.5× 68 0.4× 160 1.4× 24 0.4× 51 551
Christian Sebesta Austria 13 562 2.7× 240 1.1× 224 1.2× 94 0.8× 24 0.4× 47 845

Countries citing papers authored by Yusuke Ishibashi

Since Specialization
Citations

This map shows the geographic impact of Yusuke Ishibashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuke Ishibashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuke Ishibashi more than expected).

Fields of papers citing papers by Yusuke Ishibashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuke Ishibashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuke Ishibashi. The network helps show where Yusuke Ishibashi may publish in the future.

Co-authorship network of co-authors of Yusuke Ishibashi

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuke Ishibashi. A scholar is included among the top collaborators of Yusuke Ishibashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuke Ishibashi. Yusuke Ishibashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Takafumi, Hironori Tsujimoto, Takanori Watanabe, et al.. (2025). Clinical Significance of Coiled-Coil Domain-Containing Protein 25 Expression in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 32(5). 3839–3850. 1 indexed citations
2.
Tsujimoto, Hironori, Yoshihisa Yaguchi, Hiroyuki Horiguchi, et al.. (2025). Preoperative intestine-to-liver CT ratio: useful predictor of resection in strangulated obstruction. Emergency Radiology. 32(4). 581–589.
3.
Ishibashi, Yusuke, Satsuki Mochizuki, Keisuke Horiuchi, et al.. (2023). Periostin derived from cancer-associated fibroblasts promotes esophageal squamous cell carcinoma progression via ADAM17 activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(5). 166669–166669. 11 indexed citations
4.
Kouzu, Keita, Hironori Tsujimoto, Yusuke Ishibashi, et al.. (2021). Preoperative Fall Risk Assessment Score as a Prognostic Factor in Esophageal Cancer Patients after Esophagectomy. Journal of Clinical Medicine. 10(24). 5966–5966. 3 indexed citations
5.
Hatakeyama, Shingo, Hideo Kawaguchi, Yoshiomi Hatayama, et al.. (2021). Effects of six-cycle completion and earlier use of radium-223 therapy on prognosis for metastatic castration-resistant prostate cancer: A real-world multicenter retrospective study. Urologic Oncology Seminars and Original Investigations. 40(2). 64.e1–64.e8. 11 indexed citations
6.
Nagata, Hiromi, Hironori Tsujimoto, Hiroyuki Horiguchi, et al.. (2021). Clinical Relevance of Tissue and Serum Human Epidermal Growth Factor Receptor 2 Expression in Patients With Esophageal Squamous Cell Carcinoma. Journal of Surgical Research. 269. 189–200.
7.
Nomura, Shinsuke, Hironori Tsujimoto, Yusuke Ishibashi, et al.. (2020). Efficacy of artificial pneumothorax under two-lung ventilation in video-assisted thoracoscopic surgery for esophageal cancer. Surgical Endoscopy. 34(12). 5501–5507. 11 indexed citations
8.
Kouzu, Keita, Hironori Tsujimoto, Hidekazu Sugasawa, et al.. (2020). Modified geriatric nutrition risk index as a prognostic predictor of esophageal cancer. Esophagus. 18(2). 278–287. 23 indexed citations
9.
Nagata, Hiromi, Hironori Tsujimoto, Yoshihisa Yaguchi, et al.. (2020). Mixed adenoneuroendocrine carcinoma with loss of HER2 positivity after trastuzumab-based chemotherapy for HER2-positive gastric cancer: a case report. SHILAP Revista de lepidopterología. 6(1). 5–5.
10.
11.
Ishibashi, Yusuke, Hironori Tsujimoto, Keita Kouzu, et al.. (2020). Impact of Antiplatelet and Anticoagulant Therapies on Platelet-related Prognostic Markers in Patients With Esophageal Cancer. In Vivo. 34(4). 1941–1949. 5 indexed citations
12.
Kouzu, Keita, Hironori Tsujimoto, Makoto Nishikawa, et al.. (2019). Risk factors for nonalcoholic fatty liver disease after gastrectomy for gastric cancer. Gastric Cancer. 23(2). 356–362. 9 indexed citations
13.
Hatakeyama, Shingo, Toshiaki Tanaka, Toshikazu Tanaka, et al.. (2019). Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma. Clinical Genitourinary Cancer. 17(3). e440–e446. 19 indexed citations
14.
Hatakeyama, Shingo, Tohru Yoneyama, Yuki Tobisawa, et al.. (2019). Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer. Scientific Reports. 9(1). 16761–16761. 29 indexed citations
15.
Hatakeyama, Shingo, Toshiaki Tanaka, Toshikazu Tanaka, et al.. (2018). Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis. Medical Oncology. 36(1). 6–6. 17 indexed citations
16.
Ishibashi, Yusuke, Takuya Koie, Naoki Fujita, et al.. (2014). Tubulocystic renal cell carcinoma in the left kidney: a case report. Journal of Medical Case Reports. 8(1). 265–265. 5 indexed citations
17.
18.
Ishibashi, Yusuke, et al.. (1995). Entire course of Acanthamoeba keratitis in a patient. 46(10). 1035–1040. 1 indexed citations
19.
Soma, Y., et al.. (1989). Clinical Distribution of Anticentromere Antibody in Japanese Patients. Dermatology. 178(1). 16–19. 8 indexed citations
20.
Nakanishi, H., et al.. (1989). Atypical Scleroderma Associated with Multiple Myeloma. Dermatology. 178(3). 176–178. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vivek R. Sharma Breakdown of academic impact, for papers by Satoshi Kobayashi Breakdown of academic impact, for papers by Maria Sotiropoulou Breakdown of academic impact, for papers by Edwin Boelke Breakdown of academic impact, for papers by Chiaki Okuse Breakdown of academic impact, for papers by Martha M. Kirstein Breakdown of academic impact, for papers by Ahmet Emre Eşkazan Breakdown of academic impact, for papers by CK Lee Breakdown of academic impact, for papers by Theodore Thomas Breakdown of academic impact, for papers by Christian Sebesta
Rankless by CCL
2026